Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.8.0.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2017
Dec. 31, 2016
Current assets    
Cash and cash equivalents $ 110,536 $ 88,294
Accounts receivable 5,582 1,830
Short-term investment (certificate of deposit) 44,088 0
Cash deposits with clearing organizations 1,040 1,030
Receivables from broker-dealers and clearing organizations 8,282 3,357
Forgivable loans receivable 1,269 1,712
Securities owned, at fair value 1,595 2,357
Inventory 318 203
Other receivables - related party 638 1,790
Prepaid expenses and other current assets 10,739 9,061
Total current assets 184,087 109,634
Property and equipment, net 8,221 7,376
Restricted cash 16,886 15,860
Long-term investments, at fair value 923 1,414
Intangible asset 15,983 17,408
Goodwill 18,645 18,645
Other assets 346 394
Total assets 245,091 170,731
Current liabilities    
Accounts payable and accrued expenses 31,978 23,871
Accrued expense - related party 88 0
Accrued commissions and payroll payable 11,255 11,940
Deferred clearing and marketing credits 838 995
Deferred product revenue 680 0
Securities sold, not yet purchased, at fair value 0 298
Interest payable 161 88
Interest payable - related party 497 77
Notes payable, short-term (net of debt discount of $1,277 and $0 at September 30, 2017 and December 31, 2016, respectively) 8,223 1,000
Subsidiary convertible note, short-term, at fair value 4,733 1,031
Contingent consideration payable 637 424
Warrants issued in 2017 and issuable in 2016 - National 8,832 14,359
Contingently issuable liabilities 0 1,682
Derivative warrant liability 313 481
Other current liabilities 193 319
Total current liabilities 68,428 56,565
Notes payable, long-term (net of debt discount of $2,550 and $2,009 at September 30, 2017 and December 31, 2016, respectively) 40,734 22,528
Subsidiary convertible note, long-term, at fair value 9,928 3,656
Other long-term liabilities 4,736 5,014
Total liabilities 123,826 87,763
Commitments and contingencies
Stockholders' equity    
Common stock, $.001 par value, 100,000,000 shares authorized, 50,584,937 and 48,932,023 shares issued and outstanding as of September 30, 2017 and December 31, 2016, respectively 51 49
Common stock issuable, 86,272 and 0 shares as of September 30, 2017 and December 31, 2016, respectively 353 0
Additional paid-in-capital 338,254 283,697
Accumulated deficit (301,714) (245,251)
Total stockholders' equity attributed to the Company 36,944 38,495
Non-controlling interests 84,321 44,473
Total stockholders' equity 121,265 82,968
Total liabilities and stockholders' equity 245,091 170,731
Series C Convertible Preferred Stock [Member]    
Stockholders' equity    
Convertible preferred stock, $.001 par value, 129,767 Series C shares authorized, 0 shares issued and outstanding as of September 30, 2017 and December 31, 2016, respectively $ 0 $ 0